Cognitive limitations in occupationally active malignant brain tumour survivors

Occupational Medicine

Volumn 59, Issue 6, 2009, Pages 406-412

  Calvio, Lisseth ^a   Feuerstein, Michael ^a,b,d   Hansen, Jennifer ^a,c   Luff, Gina M ^a,c  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c AMERICAN UNIVERSITY   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Attention; Brain tumour; Cognitive limitations; Executive function; Memory; Occupational activity

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; ATTENTION DISTURBANCE; BRAIN CANCER; CANCER SURVIVOR; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; EDUCATIONAL STATUS; ETHNICITY; FATIGUE; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; INTERNET; JOB STRESS; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; ORIENTATION; PRIORITY JOURNAL; PROBLEM SOLVING; WORK CAPACITY; WORKPLACE;

ADULT; AGED; ATTENTION; BRAIN NEOPLASMS; COGNITION DISORDERS; DEPRESSION; EMPLOYMENT; EXECUTIVE FUNCTION; FATIGUE; FEMALE; GLIOMA; HEALTH BEHAVIOR; HEALTH SURVEYS; HUMANS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVORS; TIME FACTORS; YOUNG ADULT;

EID: 69549126444     PISSN: 09627480     EISSN: 14718405     Source Type: Journal    
DOI: 10.1093/occmed/kqp094     Document Type: Article

References (23)

1. ACS. Cancer Facts and Figures 2005. Atlanta: American Cancer Society, 2005.
2. Ries LAG, Eisner MP, Kosary CL et al. SEER Cancer Statistics Review, 1975-2001. Bethesda, MD: National Cancer Institute, 2004 http://seer.cancer.gov/csr/1975_2001 (4 December 2007, date last accessed).
3. Giovagnoli AR. Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumor. J Neurol Neurosurg Psychiatr 1999;67:358-363.
4. Giovagnoli AR, Boiardi A. Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci 1994;15:481-488.
5. Heimans JJ, Taphoorn MJ. Impact of brain tumour treatment on quality of life. J Neurol 2002;249:955-960.
6. Brown PD, Jensen AW, Felten SJ et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 2006;24:5427-5433.
7. Kaleita TA, Welisch DK, Cloughesy TF et al. Prediction of neurocognitive outcome in adult brain tumor patients. J Neurooncol 2004;67:245-253.
8. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: Influence of histopathology, lesion location, and treatment. J Neurooncol 1996;30:61-69.
9. Edvardsson T, Ahlstrom G. Illness-related problems and coping among persons with low-grade glioma. Psychooncology 2005;14 728-737.
10. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC. Prospective study of neuropsycholgic testing and quality-of-life assessment of adultswith primary malignant brain tumors. Int J Radiat Oncol Biol Phys 2003;55:992-999.
11. McGraw Hill Higher Education. Test Pilot Classic. 3 ed 2003.
12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
13. Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 2004;27: 14-23.
14. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance Systems Survey Questionnaire: US Department of Health and Human Services. Altanta, GA: Centers for Disease Control and Prevention, 1999.
15. Maydeu-Olivarez A, D'Zurilla TJ. A factor analytic study of the Social Problem Solving Inventory: An integration of theory and data. Cognit Ther Res 1996;20:115-133.
16. D'Zurilla TJ, Nezu AM. Development and preliminary evaluation of the Social Problem Solving Inventory. Psychol Assess: J Consult Clin Psychol 1990;2:156-163.
17. Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J Clin Oncol 2004;22:2233-2239.
18. O'Hara C, Harrell M, Bellingrath E, Lisicia K. Cognitiv Symptom Checklists: Clinician's Guide. Odessa, FL: Psychological Assessment Resources, 1993.
19. Field A. Discovering Statistics Using SPSS. 2nd edn. Thousand Oaks, CA: Sage Publications, 2005.
20. Eriksen W. Work factors as predictors of persistent fatigue: A prospective study of nurses' aides. Occup Environ Med 2006;63 428-434.
21. Reardon DA, Wen PY. Therapeutic advances in the treatment of glioblastoma: Rationale and potential role of targeted agents. Oncologist 2006;11:152-164.
22. Ahles TA, Saykin AJ, Furstenberg CT et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-493.
23. Poppelreuter M, Weis J, Kulz AK, Tucha O, Lange KW, Bartsch HH. Cognitive dysfunction and subjective complaints of cancer patients: A cross-sectional study in a cancer rehabilitation centre. Eur J Cancer 2004;40:43-49.